Such chromatin-trapping further affects the downstream cellular processes mediated by FACT, such as p53 activation, NOTCH1 suppression and NF-κβ inhibition, and thus inhibits tumor progression [22–24]. The gene discussed is SSRP1; the disease is neoplasm.